Cancer vaccines show promise for treatment and prevention
For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer. Now, a landmark phase 3 clinical trial of a personalized melanoma vaccine shows that this approach can improve outcomes for patients. Johns Hopkins Kimmel Cancer Center was among the clinical…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Infant mortality falls by 16% in some of England's most deprived areas, new national data show
United Kingdom
-
A 43-gram sugar gap separates adults who check food labels from those who rarely do
United Kingdom
-
Molecular mapping of 8 million cells brings cerebral architecture into focus
United Kingdom
-
Key brain area reveals distinct zones whose boundaries blur with age
United Kingdom
-
A 12-year study links longer TV viewing to faster kidney function decline
United Kingdom
-
Experimental blood test detects early breast cancer and predicts recurrence
United Kingdom
-
Personalized mobile health coaching offers new approach to preventing gestational diabetes in high-risk pregnancies
United Kingdom
-
Organ-on-chip shows how tumors interact with nerves and blood vessels
United Kingdom